Pediatric Perfusion Systems Market - By Product (Oxygenators, Cannulas and Catheters, Blood Pumps, Arterial Filters), By Application (Cardiac Surgeries, Organ Transplantation), By End-use (Hospitals, Cardiac Centers) – Global Forecast, 2023-2032

Pediatric Perfusion Systems Market Size

Pediatric Perfusion Systems Market size was valued at USD 318.9 million in 2022 and is projected to register a CAGR of over 6.8% between 2023 and 2032. This robust market growth is attributed to factors such as growing demand for minimally invasive procedures in pediatric cardiac surgery, increasing favorable government initiatives and reimbursement policies, and growing awareness about the importance of pediatric cardiac care, among others are driving the market development. Additionally, the rising prevalence of congenital heart defects in paediatric populations is a significant factor in the market progress.
 

Moreover, perfusion devices to facilitate corrective operations are in high demand as awareness and early identification of CHDs are on rise. For instance, according to American Heart Association, Inc.’s fact sheet 2022, congenital heart defects are expected to affect around 40,000 infants in the U.S. each year. In the first year of life, approximately 25%, or 2.4 per 1,000 live newborns, require invasive therapy. Therefore, the aforementioned factors contribute to the growth of the market by fostering advancements in technology and enhancing the overall quality of care for paediatric patients undergoing cardiac procedures.
 

Pediatric perfusion systems refer to medical devices and systems designed specifically for managing the circulation and oxygenation of blood in pediatric patients during cardiac surgery or other medical procedures requiring temporary circulatory support.
 

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the pediatric perfusion systems market, owing to disruptions in paediatric cardiac surgeries treatments. The postponement of elective procedures, particularly paediatric cardiovascular treatments, resulted in decline in the demand for perfusion systems during the pandemic's early stages. To manage the rise of COVID-19 patients, hospitals distributed resources, reducing the availability and use of paediatric perfusion systems.
 

Moreover, supply chain disruptions and financial restrictions imposed further challenges to market trends. However, as COVID-19 cases declined and healthcare systems adapted to the new norms, the paediatric perfusion systems market is expected to record healthy expansion.
 

Pediatric Perfusion Systems Market Trends

The market is influenced by several factors such as increasing advancements in perfusion technology, growing integration of extracorporeal membrane oxygenation (ECMO) technology, adoption of remote monitoring and telehealth solutions, and growing demand for personalized and precision medicine, among others.
 

• Paediatric perfusion devices are being miniaturized, which allows for increased surgical flexibility. Smaller devices are particularly relevant in paediatric procedures, when patients have restricted vascular access or require less invasive procedures.
   
• Moreover, the integration of artificial intelligence (AI) in healthcare and machine learning into paediatric perfusion systems is becoming more prevalent. These technologies are used to analyze enormous data sets, optimise perfusion applications and offer predictive analytics to improve surgical decision-making.
   

Pediatric Perfusion Systems Market Analysis

The market by product is categorized into pediatric oxygenators, pediatric cannulas and catheters, pediatric blood pumps, pediatric arterial filters, monitoring systems, and other products. The pediatric oxygenators segment garnered around USD 99.1 million revenue in 2022.
 

• Due to congenital heart defects, neonates and newborns often require cardiac surgeries or procedures. The specialised oxygenation demands of this patient demography contributes to the need for paediatric oxygenators developed to meet the physiological requirements of the youngest patients.
   
• Moreover, with a rising focus on improving paediatric cardiac care across the globe, there is an increasing demand for improved perfusion devices, such as paediatric oxygenators. Healthcare infrastructure expansion efforts in developing nations further contribute to market expansion.
   

Based on application, the pediatric perfusion systems market is segmented into cardiac surgeries, and organ transplantation. The cardiac surgeries segment dominated the market and accounted for over 89% business share in 2022 and is anticipated to witness fastest growth during the forecast period.

• While congenital heart defects are a key driving factor, there is a considerable  demand for pediatric cardiac surgeries to address acquired heart conditions, such as infections, cardiomyopathies, and rheumatic heart disease. The prevalence of these conditions contributes to the overall need for cardiac interventions in children. According to the NCBI article, congenital cardiac disease is expected to affect 3 to 10 children per 1000 live births in the U.S., and the rate is consistently rising.
   
• Additionally, increasing awareness about pediatric cardiac conditions and efforts to improve healthcare accessibility globally contribute to the growing demand for pediatric cardiac surgeries. Initiatives aimed at expanding treatment access, especially in developing regions, drive the need for comprehensive cardiac care, thereby supporting the segment progress.
   

The pediatric perfusion systems market by end-use is categorized into hospitals, cardiac centers, and other end-users. The hospitals segment accounted for over USD 249.4 million revenue in 2022.
 

• The demand for paediatric cardiac procedures, that are frequently caused by congenital heart defects or acquired cardiac diseases, drives procedural volume in hospital-settings. Advanced perfusion systems are required to facilitate safe and successful cardiac procedures in the paediatric population.
   
• Additionally, hospitals seek to provide cutting-edge healthcare services, and innovations in paediatric perfusion systems aid in their approval. Improved safety, monitoring capabilities, and greater oxygenation assistance are appealing to hospitals seeking the most recent advancements in paediatric cardiac care.
   

North America paediatric perfusion systems market accounted for USD 131.6 million revenue in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• There is a growing focus on pediatric cardiac care in the region, leading to increased investments in specialized services and technologies. Hospitals and healthcare systems are allocating resources to enhance pediatric cardiac care, thus, driving the demand for advanced perfusion systems.
   
• Furthermore, North America is a hub for technological innovations and medical research. Perfusion technological improvements, research activities, and collaborations between academic institutions and industry players all contribute to the region's development and use of cutting-edge paediatric perfusion systems.
   

Pediatric Perfusion Systems Market Share

The pediatric perfusion systems industry is fragmented in nature, with a large number of small and medium-sized companies, along with major industry players competing with each other. However, key market players are focusing on improving their market share including Medtronic, LivaNova PLC, Terumo Cardiovascular Systems Corporation, among others. The market players are focusing on strategies including innovating and developing new products and services.
 

Some of the eminent market participants operating in the pediatric perfusion systems industry include:

• Medtronic
• LivaNova PLC
• Terumo Cardiovascular Systems Corporation
• BL Lifesciences
• Cardinal Health
• EUROSETS
• Getinge AB
• Nonin
• Edwards Lifesciences Corporation
• Stryker Corporation
   

Pediatric Perfusion Systems Industry News:

• In December 2021, Medtronic plc announced that the FDA granted 510(k) clearance for its INVOS 7100 oximetry device for children aged birth to 18. It detects vital signals to assist paediatric physicians make time-critical choices about hemodynamic management, ventilation, and resuscitation for preterm babies, neonates, children, and other patients treated by paediatric clinicians.
   
• In April 2021, LivaNova PLC announced that has received FDA 510(k) approval for B-Capta, the new in-line blood-gas monitoring system incorporated into the market-leading S5 heart-lung machine (HLM). The device is designed to monitor arterial and venous blood gas parameters conveniently and accurately, even during long and difficult paediatric and adult cardiopulmonary bypass treatments.
   

Pediatric perfusion systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018-2032 (USD Million)

• Pediatric oxygenators
• Pediatric cannulas and catheters
• Pediatric blood pumps
• Pediatric arterial filters
• Monitoring systems
• Other products

By Application, 2018-2032 (USD Million)

• Cardiac surgeries
• Organ transplantation

By End-use, 2018-2032 (USD Million)

• Hospitals
• Cardiac centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa